Enveric Biosciences, Inc.·4

Mar 14, 7:24 PM ET

Coveney Kevin Michael 4

4 · Enveric Biosciences, Inc. · Filed Mar 14, 2023

Insider Transaction Report

Form 4
Period: 2023-03-13
Coveney Kevin Michael
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Common Stock

    2023-03-13+26,50026,500 total
Footnotes (2)
  • [F1]Represents restricted stock units (the "RSUs") granted to the reporting person. For each vested RSU, the reporting person will be entitled to receive one share of common stock.
  • [F2]The RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on March 13, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary